drugset / Trial / NCT00176202

Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar

NCT00176202

Phase 3 Completed 65 enrolled University of Illinois at Chicago
RandomizedParallel-groupTriple-blindTreatment

Summary

The study is to examine the null hypothesis that risperidone and divalproex sodium are equally effective in treating/stabilizing pediatric bipolar disorder.

Timeline

Start
2003-04
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Divalproex Sodium Small molecule
Comparator Risperidone Other / unclassified

Indications